Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.
Animals
Blood Glucose
/ metabolism
Diabetes Mellitus, Experimental
/ drug therapy
Diabetes Mellitus, Type 1
/ drug therapy
Diabetic Neuropathies
/ chemically induced
Disease Models, Animal
Glycated Hemoglobin
/ metabolism
Hypoglycemic Agents
/ toxicity
Insulin
/ toxicity
Male
Neural Conduction
/ drug effects
Rats
BB/OKL rats
TIND
Type 1 diabetes
peripheral neuropathy
sciatic nerve
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Feb 2021
04 Feb 2021
Historique:
received:
23
12
2020
revised:
27
01
2021
accepted:
02
02
2021
entrez:
9
2
2021
pubmed:
10
2
2021
medline:
13
4
2021
Statut:
epublish
Résumé
Treatment-induced neuropathy in diabetes (TIND) is defined by the occurrence of an acute neuropathy within 8 weeks of an abrupt decrease in glycated hemoglobin-A1c (HbA1c). The underlying pathogenic mechanisms are still incompletely understood with only one mouse model being explored to date. The aim of this study was to further explore the hypothesis that an abrupt insulin-induced fall in HbA1c may be the prime causal factor of developing TIND.
Identifiants
pubmed: 33557206
pii: ijms22041571
doi: 10.3390/ijms22041571
pmc: PMC7913916
pii:
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Diabetes Gesellschaft
ID : DDG 931000-162
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122
pubmed: 24526393
Brain. 2015 Jan;138(Pt 1):2-3
pubmed: 25564488
J Endocrinol. 2017 Apr;233(1):53-64
pubmed: 28138002
Acta Paediatr Suppl. 1999 Jan;88(427):31-4
pubmed: 10195851
ACS Nano. 2017 Jan 24;11(1):395-406
pubmed: 28001346
Eur J Pain. 2012 Oct;16(9):1271-80
pubmed: 22528550
Pain. 2018 Mar;159(3):595-602
pubmed: 29447138
Brain. 2015 Jan;138(Pt 1):43-52
pubmed: 25392197
Folia Biol (Praha). 1984;30(1):33-42
pubmed: 6714479
Ann Neurol. 2010 Apr;67(4):534-41
pubmed: 20437589
Exp Neurol. 2013 Feb;240:205-18
pubmed: 23178578
Neurosci Lett. 2004 May 6;361(1-3):184-7
pubmed: 15135924
Diabetologia. 1982 Apr;22(4):225-32
pubmed: 7047269
Diabet Med. 2020 Feb;37(2):369-370
pubmed: 31318986
Diabetologia. 1996 Nov;39(11):1377-84
pubmed: 8933008
J Neuroinflammation. 2018 Mar 27;15(1):96
pubmed: 29587798
Acta Neuropathol. 2000 Mar;99(3):257-62
pubmed: 10663967
J Pharmacol Exp Ther. 2019 Mar;368(3):535-544
pubmed: 30602591
ISRN Endocrinol. 2013 Mar 31;2013:349604
pubmed: 23606982
Curr Diab Rep. 2017 Oct 24;17(12):127
pubmed: 29064042
Brain. 1984 Sep;107 ( Pt 3):935-50
pubmed: 6478183
Pain Med. 2007 Sep;8 Suppl 2:S50-62
pubmed: 17714116
Ann Neurol. 1986 Jan;19(1):44-9
pubmed: 2418761
Acta Paediatr. 1999 Nov;88(11):1184-93
pubmed: 10591418
Neurology. 1976 May;26(5):466-71
pubmed: 177904
J Cell Physiol. 2019 Dec;234(12):22234-22241
pubmed: 31131445
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Neuroscience. 2017 Jun 23;354:136-145
pubmed: 28476321
Front Neurosci. 2020 Feb 21;14:142
pubmed: 32153361
J Neurol Sci. 2018 Jan 15;384:75-83
pubmed: 29249383
J Biol Chem. 2015 May 15;290(20):12603-13
pubmed: 25787078
Exp Neurol. 2013 Dec;250:125-35
pubmed: 24095727
Nat Neurosci. 2007 Nov;10(11):1361-8
pubmed: 17965656
J Gene Med. 2015 Aug-Sep;17(8-9):141-52
pubmed: 26190010
J Cell Biol. 2001 Jan 22;152(2):301-8
pubmed: 11266447
Acta Neuropathol. 2001 Nov;102(5):413-21
pubmed: 11699552
Muscle Nerve. 2014 Aug;50(2):257-61
pubmed: 24347162
Diabetes Care. 2005 Apr;28(4):956-62
pubmed: 15793206
Neurology. 2003 Dec 9;61(11):1607-10
pubmed: 14663052